论文部分内容阅读
目前经肝动脉插管栓塞化疗（ＴＡＣＥ）已被公认为是肝癌不能手术切除的首选方法。但大多肝癌患者合并肝硬化，肝功能较差，有的同时存在门静脉癌栓。因此，ＴＡＣＥ应用受到限制。我们采用经动脉插管肝段栓塞化疗（Ｔｒａｎｓｃａｔｈｅｔｅｒ Ａｒｔｅｒｉ－ａｌ Ｓｅｇｍｅ
At present, transcatheter arterial chemoembolization (TACE) has been recognized as the first choice for liver cancer that cannot be surgically removed. However, most patients with liver cancer with liver cirrhosis, liver function is poor, and some of the portal vein tumor thrombus. Therefore, TACE applications are limited. We use Transcatheter Arteri-al Segme